{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:40:48Z","timestamp":1792651248795,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ygyno.2020.11.005","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:44:58Z","timestamp":1605573898000},"page":"450-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immune cell composition in the endometrium of patients with a complete molar pregnancy: Effects on outcome"],"prefix":"10.1016","volume":"160","author":[{"given":"Yvonne M.","family":"Hoeijmakers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.J.","family":"Gorris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred C.G.J.","family":"Sweep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Bulten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalck K.","family":"Eysbouts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon F.A.G.","family":"Massuger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petronella B.","family":"Ottevanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda I.J.M.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ygyno.2020.11.005_bb0005","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole","volume":"203","author":"Lurain","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9742","key":"10.1016\/j.ygyno.2020.11.005_bb0010","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","article-title":"Gestational trophoblastic disease","volume":"376","author":"Seckl","year":"2010","journal-title":"Lancet (London, England)"},{"issue":"16","key":"10.1016\/j.ygyno.2020.11.005_bb0015","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMcp0900696","article-title":"Clinical practice. Molar pregnancy","volume":"360","author":"Berkowitz","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2020.11.005_bb0020","doi-asserted-by":"crossref","first-page":"284","DOI":"10.6061\/clinics\/2017(05)05","article-title":"Uterine artery doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study","volume":"72","author":"Asmar","year":"2017","journal-title":"Clinics (Sao Paulo, Brazil)"},{"issue":"5","key":"10.1016\/j.ygyno.2020.11.005_bb0025","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1097\/IGC.0000000000000976","article-title":"A novel prediction model for postmolar gestational trophoblastic neoplasia and comparison with existing models","volume":"27","author":"Zhao","year":"2017","journal-title":"Intern. J. Gynecol.Ccancer: Off. J. Intern. Gynecol. Cancer Soc."},{"issue":"3","key":"10.1016\/j.ygyno.2020.11.005_bb0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ygyno.2011.05.035","article-title":"Predicting gestational trophoblastic neoplasia (GTN): is urine hCG the answer?","volume":"122","author":"Alazzam","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.11.005_bb0035","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1095\/biolreprod.107.066324","article-title":"Expression and function of PDCD1 at the human maternal-fetal interface","volume":"79","author":"Taglauer","year":"2008","journal-title":"Biol. Reprod."},{"issue":"2","key":"10.1016\/j.ygyno.2020.11.005_bb0040","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.20050019","article-title":"A critical role for the programmed death ligand 1 in fetomaternal tolerance","volume":"202","author":"Guleria","year":"2005","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2020.11.005_bb0045","article-title":"Definitive class I human leukocyte antigen expression in gestational placentation: HLA-F, HLA-E, HLA-C, and HLA-G in extravillous trophoblast invasion on placentation, pregnancy, and parturition","volume":"77","author":"Hackmon","year":"2017","journal-title":"Am. J. Reprod. Immunol. (New York, NY: 1989)"},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.005_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0039.2004.00170.x","article-title":"Human uterine leukocytes and pregnancy","volume":"63","author":"Trundley","year":"2004","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.005_bb0055","first-page":"67","article-title":"HLA class I protein expression in the human placenta","volume":"5","author":"Blaschitz","year":"2001","journal-title":"Early Pregnancy"},{"issue":"4","key":"10.1016\/j.ygyno.2020.11.005_bb0060","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ygyno.2020.11.005_bb0065","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/IGC.0000000000000892","article-title":"PD-L1 expression in premalignant and malignant Trophoblasts from gestational trophoblastic diseases is ubiquitous and independent of clinical outcomes","volume":"27","author":"Bolze","year":"2017","journal-title":"Intern. J. Gynecol. Cancer: Off. J. Intern. Gynecol Cancer Soc."},{"issue":"2","key":"10.1016\/j.ygyno.2020.11.005_bb0070","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/PGP.0000000000000305","article-title":"PD-L1 expression in human placentas and gestational trophoblastic diseases","volume":"36","author":"Veras","year":"2017","journal-title":"Intern. J. Gynecol. Pathol.: Off. J. Intern. Soc. Gynecol. Pathol."},{"issue":"8","key":"10.1016\/j.ygyno.2020.11.005_bb0075","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/PAS.0000000000000653","article-title":"Comprehensive Immunohistochemical study of programmed cell death ligand 1 (PD-L1): analysis in 5536 cases revealed consistent expression in trophoblastic tumors","volume":"40","author":"Inaguma","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"issue":"10110","key":"10.1016\/j.ygyno.2020.11.005_bb0080","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/S0140-6736(17)32894-5","article-title":"Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia","volume":"390","author":"Ghorani","year":"2017","journal-title":"Lancet (Lond., Engl.)"},{"issue":"18_suppl","key":"10.1016\/j.ygyno.2020.11.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.18_suppl.LBA6008","article-title":"Avelumab in patients with gestational trophoblastic tumors resistant to monochemotherapy: Final outcomes of TROPHIMMUN phase II trial, cohort A","volume":"38","author":"You","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2020.11.005_bb0090","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1172\/JCI87324","article-title":"Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma","volume":"126","author":"Daud","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"7528","key":"10.1016\/j.ygyno.2020.11.005_bb0095","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ygyno.2020.11.005_bb0100","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ygyno.2007.06.028","article-title":"Immune cell profiling in normal pregnancy, partial and complete molar pregnancy","volume":"107","author":"Nagymanyoki","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"5\u20136","key":"10.1016\/j.ygyno.2020.11.005_bb0105","first-page":"261","article-title":"Age related cellular immune response against complete molar pregnancy","volume":"55","author":"Nagymanyoki","year":"2010","journal-title":"J. Reprod. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2020.11.005_bb0110","first-page":"285","article-title":"FIGO oncology committee","volume":"77","author":"FIGO staging for gestational trophoblastic neoplasia","year":"2000","journal-title":"Intern. J. Gynaecol. Obstetrics: Off. Organ Intern. Feder. Gynaecol. Obstetrics"},{"issue":"3 Pt 1","key":"10.1016\/j.ygyno.2020.11.005_bb0115","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0002-9378(12)90820-0","article-title":"Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve","volume":"168","author":"Yedema","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2020.11.005_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40425-016-0115-3","article-title":"Multiplexed tissue biomarker imaging","volume":"4","author":"Stack","year":"2016","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.005_bb0125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4049\/jimmunol.1701262","article-title":"Eight-color multiplex immunohistochemistry for simultaneous detection of multiple immune checkpoint molecules within the tumor microenvironment","volume":"200","author":"Gorris","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.ygyno.2020.11.005_bb0130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-immunol-032712-100003","article-title":"Immunology of the maternal-fetal interface","volume":"31","author":"Erlebacher","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.ygyno.2020.11.005_bb0135","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1600-0897.2009.00794.x","article-title":"The unique properties of uterine NK cells","volume":"63","author":"Manaster","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"issue":"4","key":"10.1016\/j.ygyno.2020.11.005_bb0140","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1189\/jlb.0511227","article-title":"Maternal KIR and fetal HLA-C: a fine balance","volume":"90","author":"Chazara","year":"2011","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"10.1016\/j.ygyno.2020.11.005_bb0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.it.2008.02.012","article-title":"A critical look at HLA-G","volume":"29","author":"Apps","year":"2008","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.11.005_bb0150","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ygyno.2020.05.042","article-title":"Transcriptomic and immunohistochemical approaches identify HLA-G as a predictive biomarker of gestational choriocarcinoma resistance to monochemotherapy","volume":"158","author":"Bolze","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"21","key":"10.1016\/j.ygyno.2020.11.005_bb0155","doi-asserted-by":"crossref","first-page":"13741","DOI":"10.1073\/pnas.162491699","article-title":"CD1d and invariant NKT cells at the human maternal-fetal interface","volume":"99","author":"Boyson","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.005_bb0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2001-12-0196","article-title":"Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity","volume":"100","author":"Kim","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ygyno.2020.11.005_bb0165","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/08820130802191409","article-title":"NKT cells at the maternal-fetal interface","volume":"37","author":"Boyson","year":"2008","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.ygyno.2020.11.005_bb0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0065-230X(08)00408-9","article-title":"The role of NKT cells in tumor immunity","volume":"101","author":"Terabe","year":"2008","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.ygyno.2020.11.005_bb0175","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3389\/fimmu.2018.01838","article-title":"Tissue-specific roles of NKT cells in tumor immunity","volume":"9","author":"Terabe","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ygyno.2020.11.005_bb0180","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1365-2567.1999.00726.x","article-title":"Expression of CD1D mRNA transcripts in human choriocarcinoma cell lines and placentally derived trophoblast cells","volume":"96","author":"Jenkinson","year":"1999","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.ygyno.2020.11.005_bb0185","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1073\/pnas.0511025103","article-title":"Gestation stage-dependent mechanisms of invariant natural killer T cell-mediated pregnancy loss","volume":"103","author":"Boyson","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.ygyno.2020.11.005_bb0190","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20050953","article-title":"Differential antitumor immunity mediated by NKT cell subsets in vivo","volume":"202","author":"Crowe","year":"2005","journal-title":"J. Exp. Med."},{"issue":"20","key":"10.1016\/j.ygyno.2020.11.005_bb0195","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1158\/1078-0432.CCR-05-0877","article-title":"Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas","volume":"11","author":"Tachibana","year":"2005","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.005_bb0200","first-page":"275","article-title":"Decidual infiltration of FoxP3(+) regulatory T cells, CD3(+) T cells, CD56(+) decidual natural killer cells and Ki-67 trophoblast cells in hydatidiform mole compared to normal and ectopic pregnancies","volume":"5","author":"Sundara","year":"2012","journal-title":"Mol. Med. Rep."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820341135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820341135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:55:16Z","timestamp":1758772516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820341135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0090825820341135"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.11.005","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune cell composition in the endometrium of patients with a complete molar pregnancy: Effects on outcome","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}